PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25217526-9	2014	Taken together, our results offer a preclinical proof of concept for Rubone as a lead candidate for further investigation as a new class of HCC therapeutic based on restoration of miR34a tumor-suppressor function.	2'-hydroxy-2,4,4',5,6'-pentamethylchalcone	69-75	TSC complex subunit 1	Homo sapiens	187-203